The ROIC Quality of Align Technology, Inc. The stock increased 1.92% or $4.34 during the last trading session, reaching $230.14. Sumitomo Mitsui Asset Management Company LTD increased its position in shares of Align Technology by 3.8% during the second quarter. Align Technology, Inc. (NASDAQ:ALGN) has risen 82.22% since December 5, 2016 and is uptrending. It has outperformed by 65.52% the S&P500.
Northwestern Mutual Wealth Management Company increased its stake in Align Technology Inc (ALGN) by 1615.03% based on its latest 2017Q2 regulatory filing with the SEC. The institutional investor held 69,768 shares of the health care company at the end of 2017Q2, valued at $10.47 million, down from 165,675 at the end of the previous reported quarter. Merck & Co Inc now has $152.79 billion valuation. The stock increased 0.70% or $1.58 during the last trading session, reaching $227.38. About 854,301 shares traded. It tells an investor how quickly a company is increasing its revenues. The medical equipment provider reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.19.
A number of other institutional investors have also bought and sold shares of ALGN.
The most recent non open market insider trade was completed by MORICI JOHN on 11/20/2017, and was a disposition of 1,922 shares with a final price of $255.51. (NASDAQ:ALGN). Fincl Counselors Inc has invested 0.05% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Cleararc Cap holds 1,841 shares or 0.04% of its portfolio. That transaction by Blackrock took place on September 30, 2017, the same day Renaissance Technologies Llc purchased an additional 449519 shares in ALGN to bring its total stake to 2.04 million.
Today we are spotlighting shares of Align Technology, Inc. (NASDAQ:ALGN) on Tuesday, October 17 with “Buy” rating. After $1.01 actual earnings per share reported by Align Technology,